ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 15309 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 15309; 2) Community: the network communities that were significantly associated with the response to NSC 15309; 3) Molecule: the relationships between components within communities and NSC 15309; 4) MDR: the compounds that were significantly associated with the NSC 15309.

NSC Compound Enrichment Correlation
NSC 687006 Null 0.00628187335688605 0.24242607
NSC 690266 ANTINEOPLASTIC-690266 0.00628187335688605 0.3878505
NSC 73241 Null 0.00628187335688605 0.39618946
NSC 750892 2,7-Bis-[2-(2-methoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone bis tosylate salt 0.00628187335688605 0.25194957
NSC 757055 HEXACHLOROPHENE 0.00628187335688605 0.31300463
NSC 301457 Cycloalkannin 0.00824865245912279 0.5317224
NSC 355457 11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride 0.00824865245912279 0.34547787
NSC 629595 Null 0.00824865245912279 0.66642004
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.00824865245912279 0.59053997
NSC 641245 Benzenebutanamide, N-(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)-.alpha.,.gamma.-dioxo-2-(3,4-dihydro- 3,4-dioxo-2-naphthalenyl)- 0.00824865245912279 0.43178458
Total:89  Current:16    [First] [Prev] [Next] [Last]